Lower Bioavailability and Shorter Half-Life of Voriconazole in Pediatric BMT Patients
Year: 2012
Type: article
Abstract: Voriconazole, a triazole antifungal agent with excellent oral bioavailability has been used for mold prophylaxis in transplant recipients. Lack of detailed pharmacokinetic information in the pediatric BMT setting has been an impediment to optimal dosing regimen of this agent in children.
Institutions: University of Pittsburgh, Children's Hospital of Pittsburgh
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2055376264
